MD1642Z - Фитотерапевтическая пищевая добавка для восстановления после COVID-19 - Google Patents
Фитотерапевтическая пищевая добавка для восстановления после COVID-19 Download PDFInfo
- Publication number
- MD1642Z MD1642Z MDS20210111A MDS20210111A MD1642Z MD 1642 Z MD1642 Z MD 1642Z MD S20210111 A MDS20210111 A MD S20210111A MD S20210111 A MDS20210111 A MD S20210111A MD 1642 Z MD1642 Z MD 1642Z
- Authority
- MD
- Moldova
- Prior art keywords
- extract
- dry extract
- covid
- food supplement
- post
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 10
- 208000025721 COVID-19 Diseases 0.000 title claims abstract description 9
- 238000011084 recovery Methods 0.000 title claims abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 28
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000894006 Bacteria Species 0.000 claims abstract description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 7
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 7
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 7
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 5
- 239000004310 lactic acid Substances 0.000 claims abstract description 5
- 240000001592 Amaranthus caudatus Species 0.000 claims abstract description 4
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims abstract description 4
- 244000003416 Asparagus officinalis Species 0.000 claims abstract description 4
- 235000005340 Asparagus officinalis Nutrition 0.000 claims abstract description 4
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 4
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims abstract description 4
- 244000298479 Cichorium intybus Species 0.000 claims abstract description 4
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 4
- 244000019459 Cynara cardunculus Species 0.000 claims abstract description 4
- 235000019106 Cynara scolymus Nutrition 0.000 claims abstract description 4
- 241000320380 Silybum Species 0.000 claims abstract description 4
- 235000010841 Silybum marianum Nutrition 0.000 claims abstract description 4
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 4
- 235000012735 amaranth Nutrition 0.000 claims abstract description 4
- 239000004178 amaranth Substances 0.000 claims abstract description 4
- 235000016520 artichoke thistle Nutrition 0.000 claims abstract description 4
- 229940004120 bifidobacterium infantis Drugs 0.000 claims abstract description 4
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 4
- 240000002234 Allium sativum Species 0.000 claims description 3
- 235000004611 garlic Nutrition 0.000 claims description 3
- 244000005709 gut microbiome Species 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000002503 metabolic effect Effects 0.000 abstract description 3
- 230000004936 stimulating effect Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 239000006000 Garlic extract Substances 0.000 abstract 1
- 235000020706 garlic extract Nutrition 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 description 9
- 208000036649 Dysbacteriosis Diseases 0.000 description 7
- 208000027244 Dysbiosis Diseases 0.000 description 7
- 230000007140 dysbiosis Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 241000186000 Bifidobacterium Species 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940009289 bifidobacterium lactis Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- XKJMBINCVNINCA-UHFFFAOYSA-N Alfalone Chemical compound CON(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XKJMBINCVNINCA-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108030002440 Catalase peroxidases Proteins 0.000 description 1
- 108010075016 Ceruloplasmin Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010022678 Intestinal infections Diseases 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010041940 bifikol Proteins 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- LELAOEBVZLPXAZ-UHFFFAOYSA-N iberin Chemical compound CS(=O)CCCN=C=S LELAOEBVZLPXAZ-UHFFFAOYSA-N 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000000495 immunoinflammatory effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 235000015074 other food component Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000009517 secondary packaging Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Изобретение относится к пищевой промышленности, санокреатологии и медицине, в частности к биологически активной фитотерапевтической добавке к пище, обладающей активностью стимулирования иммунитета и микрофлоры кишечника, а также снижения метаболического риска в реабилитационном периоде пост-COVID-19.Пищевая добавка, согласно изобретению, содержит, в масс. %:сухой экстракт семян амаранта17сухой экстракт корня одуванчика12сухой экстракт наземной части расторопши пятнистой10сухой экстракт чеснока13сухой экстракт корня цикория11сухой экстракт почек артишока15сухой экстракт наземной части спаржи12лиофилизированные молочнокислые бактерии штаммов Bifidobacterium infantis, Bifidobacterium longum и Lactobacillus acidophilus с титром 11 х 10910.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20210111A MD1642Z (ru) | 2021-12-28 | 2021-12-28 | Фитотерапевтическая пищевая добавка для восстановления после COVID-19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20210111A MD1642Z (ru) | 2021-12-28 | 2021-12-28 | Фитотерапевтическая пищевая добавка для восстановления после COVID-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1642Y MD1642Y (ru) | 2022-09-30 |
| MD1642Z true MD1642Z (ru) | 2023-04-30 |
Family
ID=83444943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20210111A MD1642Z (ru) | 2021-12-28 | 2021-12-28 | Фитотерапевтическая пищевая добавка для восстановления после COVID-19 |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1642Z (ru) |
-
2021
- 2021-12-28 MD MDS20210111A patent/MD1642Z/ru active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MD1642Y (ru) | 2022-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008317000B2 (en) | Probiotic compositions and methods for inducing and supporting weight loss | |
| RU2468808C2 (ru) | Способ лечения или предотвращения системного воспаления | |
| CN103582486B (zh) | 具有抗氧化活性的益生菌及其用途 | |
| CN101248900B (zh) | 一种新型固体运动饮料冲剂 | |
| CN109451727A (zh) | 益生菌和消化酶的组合物及其制备和使用方法 | |
| AU2024287150A1 (en) | Improving health of the microbiome in a human gastrointestinal system and multi-chamber probiotic delivery products therefor | |
| JP2013518842A (ja) | 乳糖不耐症またはラクターゼ欠乏症から起こる症状の治療に使用するための組成物 | |
| CN105802876B (zh) | 一种复合益生菌发酵苜蓿嫩芽粉制剂及其制备方法和应用 | |
| CN111543605A (zh) | 一种四高或肥胖人群用综合营养粉 | |
| MD1642Z (ru) | Фитотерапевтическая пищевая добавка для восстановления после COVID-19 | |
| Eliseeva | Beetroot Juice–10 Proven Health Benefits | |
| Reid | How science will help shape future clinical applications of probiotics | |
| Knüppel | Dental Power: How we can live longer and better and what role teeth play as a reflection of health | |
| Sadeghi et al. | The Impact and Role of Probiotic Bacterium Streptococcus Salivarius on Oral and Dental Health | |
| Pramod et al. | A Nutraceutical Approach in the Prevention of Vaginal Infection | |
| LeBlanc et al. | Beneficial effects of microorganisms isolated from papaya | |
| Telaku et al. | Impact of Lactobacillus Reuteri and Three Other Probiotics in Helicobacter Pylori Eradication. Open Access Maced J Med Sci. 2022 Oct 27; 10 (B): 2215-2219 | |
| WO2025059147A1 (en) | Compositions for ingestible supplements and related methods | |
| Pelton et al. | Microbiome-Disrupting Drugs | |
| Das et al. | Impact of Nutraceuticals on Gut Microbiota for the Management of Inflammatory Bowel Disease | |
| Hada et al. | Probiotics for Preventing Aging and Celecoxib and Berberine for Treating It | |
| CN106974279A (zh) | 制备适用于心脑血管病调理及其日常养护功效植物酵素的发酵组合物及制法 | |
| Yessimsitova et al. | ASTANA MEDICAL JOURNAL | |
| Code | HMF® Metabolic | |
| Cartwright | Probiotics for Crohn's & Colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued |